Table 2.
Study | Task | Data used for deep learning | US system | Total no. of images | No. of validation set images | Ground truth | Method |
---|---|---|---|---|---|---|---|
Liu et al. (2020) [17] | TACE response prediction | CEUS | Three | 130 CEUS datasets | 41 CEUS cine sets | mRECIST on CT/MRI | 3D-CNN |
Pan et al. (2019) [15] | Classification | CEUS | N/A | 4,420 images from 242 tumors | 10-Fold cross-validation | N/A | 3D-CNN |
Guo et al. (2018) [13] | Classification | CEUS | One | 93 CEUS datasets | 5-Fold cross-validation | Pathology, CT, MRI | DCCA-MKL |
Schmauch et al. (2019) [16] | Detection and classification | B-mode | N/A | 544 images | 3-Fold cross-validation 177 Images for external validation | N/A | ResNet50 |
Hassan et al. (2017) [14] | Detection and classification | B-mode | N/A | 110 images | 10-Fold cross-validation | Unsupervised learning | SSAE+SVM |
US, ultrasonography; TACE, transarterial chemoembolization; CEUS, contrast-enhanced ultrasonography; mRECIST, modified Response Evaluation Criteria in Solid Tumor; CT, computed tomography; MRI, magnetic resonance imaging; 3D, three-dimensional; CNN, convolutional neural network; N/A, not available; DCCA-MKL, deep canonical correlation analysis-multiple kernel learning; SSAE, stacked sparse auto-encoders; SVM, support vector machine.